close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sana Biotechnology, Inc

< Previous 1 2 Next >
Sana Biotechnology to Present at September 2025 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Pricing of Public Offering
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at June 2025 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at December 2024 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at September 2024 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at May and June 2024 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today